I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Immune Potentiation of PLGA Controlled-Release Vaccines for..:
Britteny J. Cassaidy
;
Brittany A. Moser
;
Ani Solanki
...
doi:10.1021/acsomega.3c06552.s001. , 2024
Link:
https://doi.org/10.1021/acsomega.3c06552.s001
RT Journal T1
Immune Potentiation of PLGA Controlled-Release Vaccines for Improved Immunological Outcomes
UL https://suche.suub.uni-bremen.de/peid=base-ftdeakinunifig:oai:figshare.com:article_25309358&Exemplar=1&LAN=DE A1 Britteny J. Cassaidy A1 Brittany A. Moser A1 Ani Solanki A1 Qing Chen A1 Jingjing Shen A1 Kristen Gotsis A1 Zoe Lockhart A1 Nakisha Rutledge A1 Matthew G. Rosenberger A1 Yixiao Dong A1 Delaney Davis A1 Aaron P. Esser- Kahn YR 2024 K1 Biochemistry K1 Microbiology K1 Cell Biology K1 Genetics K1 Molecular Biology K1 Physiology K1 Biotechnology K1 Immunology K1 Cancer K1 Space Science K1 Chemical Sciences not elsewhere classified K1 vivo studies revealed K1 potentially beneficial additive K1 particles also increased K1 new infectious diseases K1 longer period compared K1 group reported molecules K1 fewer boost doses K1 κb signaling improved K1 improved immunological outcomes K1 immune potentiators tested K1 immune potentiators enhance K1 release vaccine formulations K1 microparticles without sn50 K1 immune potentiators K1 release formulations K1 improved adjuvant K1 immune potentiation K1 vaccine ' K1 vaccine formulation K1 release vaccines K1 release poly K1 release conditions K1 related tolerability K1 less antigen K1 lactic -< K1 influence responses K1 existing effects K1 current vaccines K1 co </ K1 cell activity K1 alter nf K1 >- glycolic JF doi:10.1021/acsomega.3c06552.s001 LK http://dx.doi.org/https://doi.org/10.1021/acsomega.3c06552.s001 DO https://doi.org/10.1021/acsomega.3c06552.s001 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)